Eribulin in Combination with Anlotinib: clinical trials recruiting now

Fewer than 3 recruiting trials found.

1

Recruiting trials

2

Conditions studied

0

US states with sites

1

Countries

Phase breakdown

Phase 2 1

Conditions being studied

Condition	Trials
Breast cancer	1
HER 2 Negative Breast Cancer	1

Recruiting trials involving Eribulin in Combination with Anlotinib

A Multicenter, Single-Arm, Phase II Exploratory Study of Eribulin in Combination With Anlotinib for HER2-Negative Recurrent/Metastatic Breast Cancer Previously Treated With Antibody-Drug Conjugates
NCT07520760 · Phase: Phase 2 · Ages: 18 Years and older · Sex: Female · 1 location

Common questions

How many recruiting trials involve Eribulin in Combination with Anlotinib?

1 recruiting trial across 2 conditions.

Is this list of trials complete?

No. For the full record, search ClinicalTrials.gov.

Get notified when new trials open

One email when new recruiting trials are added. Unsubscribe anytime.